Intraoperative Protective Ventilation in Abdominal Surgery (IMPROVE Study)
- Conditions
- Protective Lung Ventilation Using:Low Tidal Volume (6-8 mL/kg Predicted Body Weight)PEEP of 6-8 cmH2OIntraoperative RMs
- Registration Number
- NCT01282996
- Lead Sponsor
- University Hospital, Clermont-Ferrand
- Brief Summary
The purpose of this study is to compare the influence of a lung protective ventilation with conventional ventilation on postoperative complications following major abdominal surgery.
- Detailed Description
Postoperative complications are associated with a significant and quantifiable rate of both morbidity and mortality, increased length of hospital stay and cost of care. Intra-abdominal surgery, especially upper abdominal surgery, is an important risk factor of both pulmonary and extra-pulmonary complications. Up to 15-20% of patients will develop postoperative respiratory failure which may require respiratory support.
Recent data from both experimental and clinical studies suggested that, compared with conventional ventilation using high tidal volume (TV) without positive end-expiratory pressure (PEEP), intraoperative lung protective ventilation using low tidal volume, PEEP and recruitment maneuvers (RM) could reduce postoperative complications. Conventional ventilation promotes sustained cytokine production and could therefore contribute to development of lung injury with in patients with normal lungs. Conversely, lung protective ventilation was found to reduce pulmonary and systemic inflammation.
The primary objective is to compare a lung protective ventilation with conventional ventilation (high tidal volumes without PEEP) during abdominal surgery: 1- Conventional ventilation with TV of 10-12 mL/kg predicted body weight (PBW) without PEEP; 2- Protective lung ventilation with TV of 6-8 mL/kg PBW, PEEP of 6-8 cmH2O and RM.
Our hypothesis is that lung protective ventilation could reduce postoperative pulmonary and extra-pulmonary complications compared with conventional ventilation.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 400
- Planned intrabdominal surgery
- Expected duration ≥ 2 hours
- Age ≥ 40 yr (and <90 yr)
- Risk of postoperative pulmonary complications (Arozullah score ≥2)
- Noninvasive ventilation in the last 30 days
- Recent history of pneumonia, ALI/ARDS (in the last 30 days)
- History of pulmonary resection
- History of neuromuscular disease
- Patient refusal
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Composite endpoint defined as incidence of major postoperative pulmonary (defined as pneumonia, need for noninvasive ventilation or need for invasive ventilation) and extrapulmonary (SIRS, sepsis and septic shock) complications during the first seven days after surgery
- Secondary Outcome Measures
Name Time Method Other postoperative complications (reintervention, wound abscess, ...) at day 15 after surgery Major complications: postoperative hypoxemia, postoperative pneumonia, acute lung injury (ALI), acute respiratory distress syndrome (ARDS), pulmonary embolism at day 15 after surgery Minor complications : atelectasis, anastomotic leakage, intrabdominal abscess at day 15 after surgery Systemic level of marker of inflammation (C Reactive protein) at day 15 after surgery Postoperative complications at day 30 after surgery at day 30 after surgery Need for ICU admission at day 30 after surgery ICU length of stay at day 30 after surgery Hospital length of stay at day 30 after surgery Mortality at day 30 after surgery Plasma levels of the soluble form of the receptor for advanced glycation end-products (sRAGE), a marker of alveolar type I cell injury before surgery, during the immediate postoperative period and on day 1, day 3 and day 7 after surgery
Trial Locations
- Locations (1)
Chu Clermont-Ferrand
🇫🇷Clermont-Ferrand, France